Study Site 002 — Boston, Massachusetts

Study Site 002 is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Study Site 002 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hypoxic-Ischemic Encephalopathy.

Sponsors: ReAlta Life Sciences, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 002?

Study Site 002 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 002 conducted?

Study Site 002 has 1 clinical trials on record, with 1 currently active. Their work covers Hypoxic-Ischemic Encephalopathy.

Is Study Site 002 accredited by Crixeo Health?

Study Site 002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.